EUVIMEDEUVIMED entdecken
Multizentrische Studie

Multicentric Preliminary Experience and Clinical Outcomes of Female Urethral Dilation Using a Paclitaxel-Coated Balloon

David Carracedo, Ghali Belkahia, María D Sánchez-Gallego, Renán Otta, Esther García Rojo, Tamara Jerez, Guillermo Celada, Clara Sánchez-Guerrero, Lucía Estebán, César Minguez, José Manuel De la Morena, Javier Romero-Otero

International Urogynecology Journal · 2026

DOI: 10.1007/s00192-026-06693-6 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Urogynecology Journal, 2026. Verfasst von David Carracedo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hospital Universitario HM Sanchinarro, Instituto de Investigación Sanitaria HM Hospitales and ROC Clinic, P.º del Gral. Martín…. Hauptthemen laut MEDLINE: Paclitaxel, Dilatation, Urethral Stricture. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND HYPOTHESIS: To evaluate the feasibility, safety, and preliminary clinical outcomes of paclitaxel-coated balloon (Optilume®) dilation in women with urethral stricture disease, a condition with limited minimally invasive treatment options. METHODS: Multicenter, retrospective case series, including nine consecutive female patients treated with Optilume® between May 2023 and November 2025. Clinical characteristics, uroflowmetry, post-void residual (PVR), and patient-reported outcomes were collected. A uroflowmetric response was defined as a ≥ 50% increase in maximum flow rate (Qmax). Symptomatic improvement was assessed using the Patient Global Impression of Improvement (PGI-I) scale. Pre- and postoperative Qmax and PVR were compared using the Wilcoxon signed-rank test. RESULTS: Nine women were included (mean age 63.2 years; SD 15.6). Median Qmax improved from 8.6 to 13.6 mL/s (p = 0.012). Median PVR decreased from 56 to 0 mL (p = 0.043). A uroflowmetric response was achieved in 66.7% (6/9). All procedures were outpatient, with no intra- or postoperative complications and no de novo stress urinary incontinence. One patient (11.1%) required reintervention for recurrence at 5 months, successfully managed with internal urethrotomy. All patients reported improvement on PGI-I: 66.7% (6/9) "very much better" and 33.3% (3/9) "better." At short-term follow-up (mean 11 months; variable), 88.9% (8/9) remained free of reintervention. CONCLUSIONS: In this small, retrospective multicenter cohort, paclitaxel-coated balloon dilation appeared feasible and was not associated with major procedure-related complications in the short term, with encouraging functional and patient-reported improvements. These findings are preliminary and hypothesis-generating; prospective controlled studies with larger samples and longer, standardized follow-up are needed to better define effectiveness and durability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelDilatationUrethral StrictureHumansFemaleMiddle AgedRetrospective StudiesTreatment OutcomeAgedFeasibility Studies

Stichwörter der Autor:innen

Drug-coated balloonFemale urethral stricturePaclitaxel minimally invasive surgeryUrethral dilation

Substanzen

Paclitaxel

Autor:innen und Institutionen

  • Department of Urology, Hospital Universitario HM Sanchinarro, Instituto de Investigación Sanitaria HM Hospitales and ROC Clinic, P.º del Gral. Martínez Campos, 17, 28010, Madrid, Spain.
  • Department of Urology, Hospital Universitario HM Sanchinarro, Instituto de Investigación Sanitaria HM Hospitales and ROC Clinic, P.º del Gral. Martínez Campos, 17, 28010, Madrid, Spain. ghalibelkahia@hotmail.com.
  • Department of Urology, Hospital Universitario Infanta Sofía; Universidad Europea de Madrid, Faculty of Medicine, Health and Sports, Department of Medicine, FIIB HUIS-HUHEN, Madrid, Spain.
  • Department of Urology, Hospital Universitario HM Montepríncipe, Instituto de Investigación Sanitaria HM Hospitales and ROC Clinic, Madrid, Spain.
  • Department of Urology, Hospital Universitario HM Puerta del Sur, Instituto de Investigación Sanitaria HM Hospitales and ROC Clinic, Madrid, Spain.

Zitieren

APA

Carracedo, D., Belkahia, G., Sánchez-Gallego, M. D., Otta, R., García Rojo, E., Jerez, T., Celada, G., Sánchez-Guerrero, C., Estebán, L., Minguez, C., De la Morena, J. M., & Romero-Otero, J. (2026). Multicentric Preliminary Experience and Clinical Outcomes of Female Urethral Dilation Using a Paclitaxel-Coated Balloon. International Urogynecology Journal. https://doi.org/10.1007/s00192-026-06693-6

Vancouver

Carracedo D, Belkahia G, Sánchez-Gallego MD, Otta R, García Rojo E, Jerez T, et al. Multicentric Preliminary Experience and Clinical Outcomes of Female Urethral Dilation Using a Paclitaxel-Coated Balloon. International Urogynecology Journal. 2026. doi:10.1007/s00192-026-06693-6

BibTeX
@article{Carracedo2026,
  author = {Carracedo, David and Belkahia, Ghali and Sánchez-Gallego, María D and Otta, Renán and García Rojo, Esther and Jerez, Tamara and Celada, Guillermo and Sánchez-Guerrero, Clara and Estebán, Lucía and Minguez, César and De la Morena, José Manuel and Romero-Otero, Javier},
  title = {Multicentric Preliminary Experience and Clinical Outcomes of Female Urethral Dilation Using a Paclitaxel-Coated Balloon},
  journal = {International Urogynecology Journal},
  year = {2026},
  doi = {10.1007/s00192-026-06693-6}
}
Kostenlos starten →